PH26764A - Enzymatic membrane method for the synthesis and separation of peptides - Google Patents
Enzymatic membrane method for the synthesis and separation of peptides Download PDFInfo
- Publication number
- PH26764A PH26764A PH35671A PH35671A PH26764A PH 26764 A PH26764 A PH 26764A PH 35671 A PH35671 A PH 35671A PH 35671 A PH35671 A PH 35671A PH 26764 A PH26764 A PH 26764A
- Authority
- PH
- Philippines
- Prior art keywords
- membrane
- method recited
- peptide
- lhe
- enzyme
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims description 118
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 85
- 238000000034 method Methods 0.000 title claims description 69
- 230000015572 biosynthetic process Effects 0.000 title claims description 44
- 238000003786 synthesis reaction Methods 0.000 title claims description 33
- 230000002255 enzymatic effect Effects 0.000 title claims description 24
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 20
- 238000000926 separation method Methods 0.000 title description 7
- 239000000203 mixture Substances 0.000 claims description 44
- 102000004190 Enzymes Human genes 0.000 claims description 43
- 108090000790 Enzymes Proteins 0.000 claims description 43
- 229940088598 enzyme Drugs 0.000 claims description 43
- 239000011541 reaction mixture Substances 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 28
- -1 polypropylene Polymers 0.000 claims description 24
- 239000012510 hollow fiber Substances 0.000 claims description 22
- 108090001109 Thermolysin Proteins 0.000 claims description 19
- 229960005190 phenylalanine Drugs 0.000 claims description 19
- 150000002500 ions Chemical class 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- 241000894007 species Species 0.000 claims description 15
- 108090000371 Esterases Proteins 0.000 claims description 14
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 14
- 238000009833 condensation Methods 0.000 claims description 14
- 230000005494 condensation Effects 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 13
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 13
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 13
- 108091005804 Peptidases Proteins 0.000 claims description 12
- 102000035195 Peptidases Human genes 0.000 claims description 12
- 229960005261 aspartic acid Drugs 0.000 claims description 12
- 238000000502 dialysis Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000004743 Polypropylene Substances 0.000 claims description 8
- VSDUZFOSJDMAFZ-UHFFFAOYSA-N methyl 2-amino-3-phenylpropanoate Chemical compound COC(=O)C(N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920001155 polypropylene Polymers 0.000 claims description 8
- 108010003977 aminoacylase I Proteins 0.000 claims description 7
- 230000002797 proteolythic effect Effects 0.000 claims description 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- CWNSVVHTTQBGQB-UHFFFAOYSA-N N,N-Diethyldodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CC)CC CWNSVVHTTQBGQB-UHFFFAOYSA-N 0.000 claims description 6
- 125000005907 alkyl ester group Chemical group 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000003704 aspartic acid Nutrition 0.000 claims description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 235000019419 proteases Nutrition 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 102100025981 Aminoacylase-1 Human genes 0.000 claims description 4
- 229960002376 chymotrypsin Drugs 0.000 claims description 4
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 101710143180 Aminoacylase-1 Proteins 0.000 claims description 3
- 108090000317 Chymotrypsin Proteins 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108010056079 Subtilisins Proteins 0.000 claims description 3
- 102000005158 Subtilisins Human genes 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000007942 carboxylates Chemical class 0.000 claims description 3
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 102000005741 Metalloproteases Human genes 0.000 claims description 2
- 108010006035 Metalloproteases Proteins 0.000 claims description 2
- 108010022999 Serine Proteases Proteins 0.000 claims description 2
- 102000012479 Serine Proteases Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 101000621261 Xanthomonas sp. (strain T-22) Xanthomonalisin Proteins 0.000 claims description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims description 2
- 235000019833 protease Nutrition 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000005968 1-Decanol Substances 0.000 claims 1
- 241000590020 Achromobacter Species 0.000 claims 1
- 108090000145 Bacillolysin Proteins 0.000 claims 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 1
- 102000035092 Neutral proteases Human genes 0.000 claims 1
- 108091005507 Neutral proteases Proteins 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000000047 product Substances 0.000 description 84
- 239000012071 phase Substances 0.000 description 56
- 238000006243 chemical reaction Methods 0.000 description 41
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 30
- 239000000605 aspartame Substances 0.000 description 29
- 229960003438 aspartame Drugs 0.000 description 29
- 108010011485 Aspartame Proteins 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 235000010357 aspartame Nutrition 0.000 description 27
- 239000000243 solution Substances 0.000 description 26
- 239000000376 reactant Substances 0.000 description 25
- 108010016626 Dipeptides Proteins 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 17
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- 238000011160 research Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 230000032258 transport Effects 0.000 description 10
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 6
- 239000003456 ion exchange resin Substances 0.000 description 6
- 229920003303 ion-exchange polymer Polymers 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000008729 phenylalanine Nutrition 0.000 description 6
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 150000004702 methyl esters Chemical group 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229920013683 Celanese Polymers 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- VSDUZFOSJDMAFZ-SECBINFHSA-N methyl (2r)-2-amino-3-phenylpropanoate Chemical compound COC(=O)[C@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-SECBINFHSA-N 0.000 description 4
- 108010005636 polypeptide C Proteins 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 3
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 3
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 241000228257 Aspergillus sp. Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AWJGUZSYVIVZGP-YUMQZZPRSA-N Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 AWJGUZSYVIVZGP-YUMQZZPRSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- YFGBQHOOROIVKG-BHDDXSALSA-N (2R)-2-[[(2R)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound C([C@H](C(=O)N[C@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 YFGBQHOOROIVKG-BHDDXSALSA-N 0.000 description 1
- POLGZPYHEPOBFG-NSHDSACASA-N (2s)-2-benzamido-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)C1=CC=CC=C1 POLGZPYHEPOBFG-NSHDSACASA-N 0.000 description 1
- FORGMRSGVSYZQR-UHFFFAOYSA-N 2-amino-4-methylpentanamide Chemical compound CC(C)CC(N)C(N)=O FORGMRSGVSYZQR-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- UDTSPKADQGPZFS-UHFFFAOYSA-N 5-benzylideneimidazolidine-2,4-dione Chemical compound N1C(=O)NC(=O)C1=CC1=CC=CC=C1 UDTSPKADQGPZFS-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010010737 Ceruletide Proteins 0.000 description 1
- 108700033921 EC 3.4.23.20 Proteins 0.000 description 1
- 108010051021 Eledoisin Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 102400000243 Leu-enkephalin Human genes 0.000 description 1
- 108010022337 Leucine Enkephalin Proteins 0.000 description 1
- 102400000988 Met-enkephalin Human genes 0.000 description 1
- 108010042237 Methionine Enkephalin Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229930190815 caerulein Natural products 0.000 description 1
- 230000006315 carbonylation Effects 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- YRALAIOMGQZKOW-HYAOXDFASA-N ceruletide Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)[C@@H](C)O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(OS(O)(=O)=O)C=C1 YRALAIOMGQZKOW-HYAOXDFASA-N 0.000 description 1
- 229960001706 ceruletide Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical group [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- AYLPVIWBPZMVSH-FCKMLYJASA-N eledoisin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1NC(=O)CC1)C1=CC=CC=C1 AYLPVIWBPZMVSH-FCKMLYJASA-N 0.000 description 1
- 229950011049 eledoisin Drugs 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000000058 esterolytic effect Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960004905 gramicidin Drugs 0.000 description 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- SWVMLNPDTIFDDY-SBSPUUFOSA-N methyl (2r)-2-amino-3-phenylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@H](N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-SBSPUUFOSA-N 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 108010091742 peptide F Proteins 0.000 description 1
- RJSZPKZQGIKVAU-UXBJKDEOSA-N peptide f Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C(C)C)C(C)C)C1=CC=CC=C1 RJSZPKZQGIKVAU-UXBJKDEOSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- YRALAIOMGQZKOW-UHFFFAOYSA-N sulfated caerulein Natural products C=1C=CC=CC=1CC(C(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C1NC(=O)CC1)CC1=CC=C(OS(O)(=O)=O)C=C1 YRALAIOMGQZKOW-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
- C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
- C07K5/0613—Aspartame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/813—Continuous fermentation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/819—Fermentation vessels in series
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/897,679 US5037741A (en) | 1986-08-18 | 1986-08-18 | Enzymatic method for the synthesis and separation of peptides |
| US07/078,504 US5002871A (en) | 1986-08-18 | 1987-07-28 | Enzymatic membrane method for the synthesis and separation of peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH26764A true PH26764A (en) | 1992-09-28 |
Family
ID=26760616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH35671A PH26764A (en) | 1986-08-18 | 1987-08-14 | Enzymatic membrane method for the synthesis and separation of peptides |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5002871A (de) |
| EP (1) | EP0321479B1 (de) |
| JP (1) | JPH06319592A (de) |
| KR (1) | KR900004070B1 (de) |
| CN (1) | CN1026498C (de) |
| AR (1) | AR242264A1 (de) |
| AT (1) | ATE102654T1 (de) |
| AU (1) | AU610520B2 (de) |
| DE (1) | DE3789309T2 (de) |
| DK (1) | DK209388D0 (de) |
| EG (1) | EG18454A (de) |
| ES (1) | ES2007103A6 (de) |
| FI (1) | FI884359A (de) |
| GB (1) | GB2218991B (de) |
| GR (1) | GR871290B (de) |
| IL (2) | IL98061A (de) |
| MX (1) | MX168598B (de) |
| NZ (2) | NZ221467A (de) |
| PH (1) | PH26764A (de) |
| PT (1) | PT85548B (de) |
| SG (1) | SG35491G (de) |
| WO (1) | WO1988001298A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244791A (en) * | 1984-05-29 | 1993-09-14 | Genecor International, Inc. | Methods of ester hydrolysis |
| US5055399A (en) * | 1985-01-15 | 1991-10-08 | Genentech, Inc. | Enzymatic synthesis of alpha-L-aspartyl-L-phenyalanine lower alkyl esters |
| US5350681A (en) * | 1986-08-18 | 1994-09-27 | The Coca-Cola Company | Enzymatic membrane method for the synthesis and separation of peptides |
| US5202235A (en) * | 1986-08-18 | 1993-04-13 | The Coca-Cola Company | Enzymatic method for the synthesis and separation of peptides |
| US5336601A (en) * | 1986-08-18 | 1994-08-09 | The Coca-Cola Company | Enzymatic membrane method for the snythesis and separation of peptides |
| US4800162A (en) * | 1987-04-01 | 1989-01-24 | Sepracor, Inc. | Method for resolution of steroisomers in multiphase and extractive membrane reactors |
| WO1990012883A1 (en) * | 1989-04-24 | 1990-11-01 | The Coca-Cola Company | Enzymatic membrane method for the synthesis and separation of peptides |
| US5314807A (en) * | 1991-03-29 | 1994-05-24 | Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha | Method for producing an angiotensin converting enzyme inhibitor-containing composition |
| WO1992018516A1 (en) * | 1991-04-12 | 1992-10-29 | The Children's Hospital Of Philadelphia | Novel endopeptidase |
| US6271023B1 (en) * | 1997-02-04 | 2001-08-07 | Akzo Nobel N.V. | Module made of at least two-type hollow fibres, and production of same |
| FR2777803B1 (fr) * | 1998-04-24 | 2000-07-28 | Univ Claude Bernard Lyon | Procede d'elimination active et selective de petites molecules par pompage enzymatique : dialyse active |
| US6500571B2 (en) * | 1998-08-19 | 2002-12-31 | Powerzyme, Inc. | Enzymatic fuel cell |
| US6599754B2 (en) * | 2000-04-21 | 2003-07-29 | University Of Rochester | Biphasic reaction vessel and methods of use |
| US6485650B1 (en) * | 2000-08-28 | 2002-11-26 | Facilichem, Inc. | Liquid membrane separation of enantiomers |
| US20020114906A1 (en) * | 2000-11-20 | 2002-08-22 | Bridgestone Corporation | Base body for photosensitive drum and photosensitive drum using the same |
| CN117820437B (zh) * | 2023-03-24 | 2024-07-05 | 东阿辰康药业有限公司 | 菊芋肽、其制备方法及其在护肾辅助糖尿病治疗抗氧化产品中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE454512A (de) * | 1943-02-23 | |||
| US3625734A (en) * | 1969-10-16 | 1971-12-07 | Usa | Ultra-thin liquid membrane construction |
| US3779907A (en) * | 1970-04-13 | 1973-12-18 | Exxon Research Engineering Co | Liquid membrane process for the separation of aqueous mixtures |
| CA947214A (en) * | 1971-04-02 | 1974-05-14 | Antoine D'iorio | Resolution of racemates of ring-substituted phenylalanines |
| US3933781A (en) * | 1973-11-05 | 1976-01-20 | Monsanto Company | Process for the preparation of α-L-aspartyl-L-phenylalanine alkyl esters |
| US4119493A (en) * | 1975-10-23 | 1978-10-10 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
| DE2804892A1 (de) * | 1977-02-09 | 1978-08-10 | Procter & Gamble | Verfahren zur herstellung von l-threonin und dessen n-acylderivat |
| US4187086A (en) * | 1977-06-15 | 1980-02-05 | General Electric Company | Packaged membrane system and replenishment method |
| US4119408A (en) * | 1977-06-22 | 1978-10-10 | General Electric Company | Apparatus for maintaining the separation efficiency of immobilized liquid membranes in gas separation |
| US4251631A (en) * | 1978-02-23 | 1981-02-17 | Research Products Rehovot Ltd. | Cross-linked enzyme membrane |
| GB2047564B (en) * | 1978-03-27 | 1983-01-26 | Bend Res Inc | Separator membrane and process using such membrane for removing ions from an aqueous solution |
| DE2907450A1 (de) * | 1979-02-26 | 1980-09-04 | Rehovot Res Prod | Verfahren zur trennung eines waessrigen loesungsgemisches durch elektrodialyse |
| AU545416B2 (en) * | 1979-04-06 | 1985-07-11 | Carlsberg Biotechnology Ltd. A/S | A process for enzymatic production of peptides |
| EP0075160B1 (de) * | 1981-09-21 | 1987-01-07 | Toyo Soda Manufacturing Co., Ltd. | Verfahren zur Gewinnung eines Dipeptidderivates |
| US4455210A (en) * | 1982-03-04 | 1984-06-19 | General Electric Company | Multi layer ion exchanging membrane with protected interior hydroxyl ion rejection layer |
| JPS59183825A (ja) * | 1983-04-04 | 1984-10-19 | Nippon Oil & Fats Co Ltd | 不均一系反応方法 |
| EP0124313B1 (de) * | 1983-04-28 | 1989-08-02 | Ajinomoto Co., Inc. | Verfahren zur Herstellung von L-Aspartyl-L-Phenylalanin Methyl-Ester oder von L-Aspartyl-L-Phenylalanin |
| JPS60164495A (ja) * | 1984-01-16 | 1985-08-27 | モンサント コンパニー | Ｎ‐ホルミルアミノ酸とペプチド残基の酵素的結合法 |
| DE3438189A1 (de) * | 1984-10-18 | 1986-04-24 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung aromatisch substituierter l-aminosaeuren |
| EP0188342B1 (de) * | 1985-01-15 | 1992-05-13 | Genentech, Inc. | Verfahren und Vorrichtung für enzymatische Synthese |
| US4743547A (en) * | 1985-04-09 | 1988-05-10 | Kuraray Co., Ltd. | Method of producing L-phenylalanine |
-
1987
- 1987-07-28 US US07/078,504 patent/US5002871A/en not_active Expired - Fee Related
- 1987-08-14 KR KR1019880700343A patent/KR900004070B1/ko not_active IP Right Cessation
- 1987-08-14 PH PH35671A patent/PH26764A/en unknown
- 1987-08-14 AT AT87905545T patent/ATE102654T1/de not_active IP Right Cessation
- 1987-08-14 WO PCT/US1987/002030 patent/WO1988001298A2/en active IP Right Grant
- 1987-08-14 EP EP87905545A patent/EP0321479B1/de not_active Expired - Lifetime
- 1987-08-14 DE DE3789309T patent/DE3789309T2/de not_active Expired - Fee Related
- 1987-08-14 AU AU78543/87A patent/AU610520B2/en not_active Ceased
- 1987-08-17 GR GR871290A patent/GR871290B/el unknown
- 1987-08-17 NZ NZ221467A patent/NZ221467A/xx unknown
- 1987-08-17 IL IL98061A patent/IL98061A/xx unknown
- 1987-08-17 IL IL83564A patent/IL83564A/xx not_active IP Right Cessation
- 1987-08-17 NZ NZ231657A patent/NZ231657A/en unknown
- 1987-08-18 MX MX007808A patent/MX168598B/es unknown
- 1987-08-18 EG EG47887A patent/EG18454A/xx active
- 1987-08-18 PT PT85548A patent/PT85548B/pt not_active IP Right Cessation
- 1987-08-18 CN CN87106791A patent/CN1026498C/zh not_active Expired - Fee Related
- 1987-08-18 AR AR87308462A patent/AR242264A1/es active
- 1987-08-18 ES ES8702429A patent/ES2007103A6/es not_active Expired
-
1988
- 1988-04-15 DK DK209388A patent/DK209388D0/da not_active Application Discontinuation
- 1988-09-22 FI FI884359A patent/FI884359A/fi not_active Application Discontinuation
-
1989
- 1989-02-14 GB GB8903271A patent/GB2218991B/en not_active Expired - Lifetime
-
1991
- 1991-05-09 SG SG35491A patent/SG35491G/en unknown
-
1994
- 1994-05-20 JP JP6129911A patent/JPH06319592A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ231657A (en) | 1991-07-26 |
| WO1988001298A2 (en) | 1988-02-25 |
| WO1988001298A3 (en) | 1988-04-07 |
| DE3789309D1 (de) | 1994-04-14 |
| NZ221467A (en) | 1990-07-26 |
| DK209388A (da) | 1988-04-15 |
| EP0321479A1 (de) | 1989-06-28 |
| DK209388D0 (da) | 1988-04-15 |
| SG35491G (en) | 1991-06-21 |
| GR871290B (en) | 1987-12-23 |
| GB2218991B (en) | 1991-02-13 |
| MX168598B (es) | 1993-06-01 |
| GB2218991A (en) | 1989-11-29 |
| AU610520B2 (en) | 1991-05-23 |
| ATE102654T1 (de) | 1994-03-15 |
| EP0321479B1 (de) | 1994-03-09 |
| IL83564A (en) | 1992-03-29 |
| AR242264A1 (es) | 1993-03-31 |
| AU7854387A (en) | 1988-03-08 |
| EG18454A (en) | 1994-10-30 |
| PT85548A (en) | 1987-09-01 |
| PT85548B (pt) | 1990-05-31 |
| KR880701778A (ko) | 1988-11-05 |
| US5002871A (en) | 1991-03-26 |
| CN87106791A (zh) | 1988-05-04 |
| IL83564A0 (en) | 1988-01-31 |
| CN1026498C (zh) | 1994-11-09 |
| IL98061A (en) | 1992-03-29 |
| GB8903271D0 (en) | 1989-08-23 |
| FI884359A0 (fi) | 1988-09-22 |
| FI884359A (fi) | 1988-09-22 |
| ES2007103A6 (es) | 1989-06-01 |
| DE3789309T2 (de) | 1994-10-06 |
| KR900004070B1 (ko) | 1990-06-11 |
| JPH06319592A (ja) | 1994-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH26764A (en) | Enzymatic membrane method for the synthesis and separation of peptides | |
| US5350681A (en) | Enzymatic membrane method for the synthesis and separation of peptides | |
| EP0359399B1 (de) | Verfahren zur enzymatischen Herstellung von Dipeptiden | |
| US5037741A (en) | Enzymatic method for the synthesis and separation of peptides | |
| CN1185043C (zh) | 从含水混合物中分离有机物质的方法 | |
| US5057415A (en) | Continuous enzymatic process for preparing peptides | |
| Houng et al. | Kinetic resolution of amino acid esters catalyzed by lipases | |
| US5336601A (en) | Enzymatic membrane method for the snythesis and separation of peptides | |
| US5202235A (en) | Enzymatic method for the synthesis and separation of peptides | |
| CA1314254C (en) | Enzymatic membrane method for the synthesis and separation of peptides | |
| US6949658B2 (en) | Process for producing optically active α-amino acid and optically active α-amino acid amide | |
| AU598452B2 (en) | Method and apparatus for enzymatic synthesis | |
| AU641161B2 (en) | Enzymatic membrane method for the synthesis and separation of peptides | |
| Ricks et al. | Highly enantioselective hydrolysis of (R, S)‐phenylalanine isopropyl ester by Subtilisin Carlsberg. Continuous synthesis of (S)‐phenylalanine in a hollow fiber/liquid membrane reactor | |
| NO172064B (no) | Fremgangsmaate for enzymatisk syntese av peptider og fremgangsmaate for enzymatisk separering av racemiske karboksylsyreforbindelser | |
| US5055399A (en) | Enzymatic synthesis of alpha-L-aspartyl-L-phenyalanine lower alkyl esters | |
| CA2444579A1 (en) | Process for producing n-formylamino acid and utilization thereof | |
| JP2855596B2 (ja) | 成分分離方法 | |
| KR970002910B1 (ko) | 촉매환원 방법에 의한 아스파탐의 제조방법 | |
| JPH11103887A (ja) | Ｄ−アミノ酸の製造法 | |
| Rethwisch et al. | Enzymatic Catalysis in Bioseparations | |
| JP2000060593A (ja) | ＧｌｙＰｈｅの前駆体を合成する方法 |